Plasmapheresis and Immunosuppressive Therapy
- 1 June 1979
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 115 (6) , 728-730
- https://doi.org/10.1001/archderm.1979.04010060036025
Abstract
A patient with pemphigus vulgaris and serious side effects of steroid therapy was treated by exchange plasmapheresis. Eight plasmaphereses were performed over six weeks. Each procedure reduced the serum level of intercellular antibodies by 50% to 87%. A rebound in levels of intercellular antibodies usually followed their depletion but could be minimized or completely suppressed by administration of cyclophosphamide. After six weeks of therapy, clinical symptoms had greatly improved and intercellular antibody levels had decreased from a titer of 5,120 to 160. It is not possible to ascribe these improvements specifically to plasmapheresis since the patient was concurrently receiving low doses of prednisone and intermittent treatment with cyclophosphamide. (Arch Dermatol 115:728-730, 1979)Keywords
This publication has 4 references indexed in Scilit:
- Plasma exchange in the treatment of pemphigus vulgarisBritish Journal of Dermatology, 1978
- REMISSION OF MYASTHENIA GRAVIS FOLLOWING PLASMA-EXCHANGEThe Lancet, 1976
- A Model for the Regulation of Antibody Synthesis by Serum Antibody**This work was done under the sponsorship of the Commission on Immunization of the Armed Forces Epidemiological Board and was supported in part by the U. S. Army Medical Research Development Command, Department of the Army, under research contract DADA 17-69-C 9177, in part by U. S. Public Health Service Grant AI-0834, and by the National Science Foundation Grant GB-7473-X.Published by Elsevier ,1971
- Safety and Long‐term Effects of PlasmapheresisTransfusion, 1970